Labelled an effort to fight the growing issue of opioid addiction here within the province of Ontario, the Ministry of Health and Long-Term Care has announced that the provincial drug formulary (ODB) will no longer be covering high-dose long-acting opioids over 200mg MED (Morphine Equivalent Dose) as of January 2017.
A pair of articles from the London Free Press has highlighted a disturbing 400% increase in heart valve infections since 2009 amongst intravenous Hydromorph Contin users in London, Ontario.
If you pick yourself up a copy of today's (August 19th, 2015) print of The Globe & Mail, or visit their website, you might just stumble across a recognizable face in the National Section!
Hint: IT'S ME!
By K. Lanktree
- Freelance Writer -
- Blog Mistress -
- Former IV Drug User -
- Methadone Patient -
- Lover of all things Harm Reduction -
Help keep 'Studio L' online by donating to help offset the costs! Thanks💋